SPX4,071.70-4.87 -0.12%
DIA344.74+0.33 0.10%
IXIC11,461.50-20.95 -0.18%

INNOVATE Corp's MediBeacon Receives $10M In Amended Agreements With Huadong Medicine

Benzinga · 11/16/2022 06:56

MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced amendments to its commercial partnership with Huadong Medicine Co., Ltd., which trades on the Shenzhen Stock Exchange. MediBeacon is a medical technology company specializing in the advances of fluorescent tracer agents and transdermal measurement.